Australia - English - Department of Health (Therapeutic Goods Administration)

ikaria australia pty ltd - 46914 - photopheresis system lamp assembly - therakos? cellex? photopheresis system lamp assembly is indicated for extracorporeal photopheresis (reusable)

Australia - English - Department of Health (Therapeutic Goods Administration)

ikaria australia pty ltd - 46912 - photopheresis system - the therakos? cellex? photopheresis system instrument systems are indicated for the administration of photopheresis.

United States - English - NLM (National Library of Medicine)

therakos, inc. - methoxsalen (unii: u4vj29l7bq) (methoxsalen - unii:u4vj29l7bq) - methoxsalen 20 ug in 1 ml - uvadex® (methoxsalen) sterile solution is indicated for extracorporeal administration with the therakos® cellex® photopheresis system in the palliative treatment of the skin manifestations of cutaneous t-cell lymphoma (ctcl) that is unresponsive to other forms of treatment. - uvadex® (methoxsalen) sterile solution is contraindicated in patients exhibiting idiosyncratic or hypersensitivity reactions to methoxsalen, other psoralen compounds or any of the excipients. patients possessing a specific history of a light sensitive disease state should not initiate methoxsalen therapy. diseases associated with photosensitivity include lupus erythematosus, porphyria cutanea tarda, erythropoietic protoporphyria, variegate porphyria, xeroderma pigmentosum and albinism. - uvadex® sterile solution is contraindicated in patients with aphakia, because of the significantly increased risk of retinal damage due to the absence of lenses. - patients should not receive uvadex® if they have any contraindications to the photop

Australia - English - Department of Health (Therapeutic Goods Administration)

medtel pty ltd -

Australia - English - Department of Health (Therapeutic Goods Administration)

medtel pty ltd -

Canada - English - Health Canada

therakos inc - methoxsalen - solution - 20mcg - methoxsalen 20mcg - pigmenting agents

Singapore - English - HSA (Health Sciences Authority)

transmedic pte ltd - general hospital - indicated for the administration of photopheresis.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

therakos (uk) ltd - methoxsalen - solution for blood fraction modification - 20microgram/1ml

Australia - English - Department of Health (Therapeutic Goods Administration)

ikaria australia pty ltd - 46913 - photopheresis system blood set - therakos? cellex? photopheresis system procedural kit is indicated for extracorporeal photopheresis (single use)

Australia - English - Department of Health (Therapeutic Goods Administration)

ikaria australia pty ltd - methoxsalen, quantity: 0.2 mg - injection, concentrated - excipient ingredients: ethanol; glacial acetic acid; propylene glycol; sodium acetate trihydrate; sodium chloride; water for injections; sodium hydroxide - uvadex (methoxsalen) is indicated for extracorporeal administration with the therakos cellex photopheresis system for the: ? treatment of steroid-refractory and steroid-intolerant chronic graft versus host disease (cgvhd) in adults following allogeneic hsc transplantation. ? palliative treatment of the skin manifestations of cutaneous t-cell lymphoma (ctcl) that is unresponsive to other forms of treatment.